View of Assessment of Clinical Manifestation and Prognostic Risks for Patients with Philadelphia –Negative Myeloproliferative Neosplasms (MPN) by IPSET- Thrombosis, IPSS and DIPPSS Model

Return to Article Details Assessment of Clinical Manifestation and Prognostic Risks for Patients with Philadelphia –Negative Myeloproliferative Neosplasms (MPN) by IPSET- Thrombosis, IPSS and DIPPSS Model Download Download PDF